⌘K

Home/Filings/4/0001493152-23-013737

4//SEC Filing

Bruce Gerald W 4

Accession 0001493152-23-013737

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Apr 25, 8:00 PM ET

Accepted

Apr 26, 9:00 PM ET

Size

5.2 KB

Accession

0001493152-23-013737

Insider Transaction Report

Form 4

Period: 2023-04-24

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Award
Stock Option (right to buy)
2023-04-24+100,000→ 100,000 total
Exercise: $0.73From: 2023-04-24Exp: 2033-04-24→ Common Stock (100,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001361013

Filing Metadata

Form type: 4
Filed: Apr 25, 8:00 PM ET
Accepted: Apr 26, 9:00 PM ET
Size: 5.2 KB

View on SEC.gov